Keywords: ضد VEGF; Retinal pigment epithelial detachment; Photodynamic therapy; Anti-VEGF; Macular degeneration;
مقالات ISI ضد VEGF (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد VEGF; Anti-VEGF; Diabetic macular edema; Diabetic retinopathy; Dry retina; Ranibizumab; Anti-VEGF; Ådème maculaire diabétique; Rétinopathie diabétique; Assèchement rétinien; Ranibizumab;
Keywords: ضد VEGF; AMD; age-related macular degeneration; anti-VEGF; anti-vascular endothelial growth factor; CNV; choroidal neovascularization; ETDRS; Early Treatment Diabetic Retinopathy Study; PRN; Pro re nata; SD; standard deviation;
Keywords: ضد VEGF; Diabetic macular edema; Diabetes; Anti-VEGF; Safety; Multidisciplinary teams;
Keywords: ضد VEGF; Metastatic colorectal cancer; Primary tumour location; Sidedness; Prognostic biomarker; Predictive biomarker; Cetuximab; Panitumumab; Bevacizumab; Anti-EGFR; Anti-VEGF;
Keywords: ضد VEGF; Retina; Choroid; Macula; Degeneration; Angiogenesis; Anti-VEGF;
Keywords: ضد VEGF; Diabetic retinopathy; Diabetic macular edema; Anti-VEGF; Laser photocoagulation; Corticosteroids;
Keywords: ضد VEGF; Predictive Markers; Prognostic Markers; Colorectal Cancer; Molecular Subtypes; RAS; BRAF; MSI; DNA Mismatch Repair; Immunotherapy; Targeted Therapy; Biologics; Anti-EGFR; Anti-VEGF; CCS; colon cancer subtypes; CIMP; CpG island methylator phenotype; CIN; c
Keywords: ضد VEGF; Dendrimer; Ocular drug delivery; Triamcinolone acetonide; Anti-inflammatory; Anti-VEGF; Microglial cells; Human retinal pigment epithelium
Keywords: ضد VEGF; Thrombotic microangiopathy; anti-VEGF; chemotherapy; ACDIT; DIC; disseminated intravascular coagulopathy; onco-nephrology; review; drug-induced TMA;
Keywords: ضد VEGF; anti-VEGF; bevacizumab; Histoplasma capsulatum; histoplasmosis; ocular histoplasmosis syndrome; photocoagulation; photodynamic therapy; presumed ocular histoplasmosis syndrome; ranibizumab; submacular surgery;
Keywords: ضد VEGF; anti-VEGF; CNS metastasis; Kidney cancer; mTOR inhibitors; Survival;
Keywords: ضد VEGF; Hyponatremia; Renal cell cancer; Anti-VEGF; Prognostic factors
Keywords: ضد VEGF; Aging; Vision; Ocular; Ophthalmology; Ophthalmic; Low-vision; Vision loss; Blindness; Sight; Cataract; Glaucoma; Diabetic retinopathy; Proliferative diabetic retinopathy; Diabetic macular edema; Retinal vein occlusion; Central retinal vein occlusion; Brac
Keywords: ضد VEGF; Angioid streaks; Choroidal neovascularisation membrane; Acceleration/deceleration trauma; Fluorescein angiography; Anti-VEGFEstrías angioides; Membrana neovascular coroidea; Trauma por aceleración/desaceleración; Angiografía fluoresceínica; Anti-VEGF
Keywords: ضد VEGF; Choroidal osteoma; Anti-VEGF; Ranibizumab; Choroidal neovascularization
Keywords: ضد VEGF; anti-VEGF; choroidal neovascularization; Fuchs' spot; macular hemorrhage; pathologic myopia
Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration
Keywords: ضد VEGF; Anti-VEGF; Proliferative diabetic retinopathy; Retinal reperfusion; Ranibizumab; Protocol-S;
The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries
Keywords: ضد VEGF; Branch retinal vein occlusion; BVO; Anti-VEGF; Geographic variation; Medicare;
A Proximity Extension Assay (PEA)-based method for quantification of bevacizumab
Keywords: ضد VEGF; Proximity Extension Assay (PEA); Bevacizumab; Anti-VEGF; Systemic concentration; Intravitreal administration;
KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease
Keywords: ضد VEGF; mCRC; KRAS mutation; PI3KCA mutation; FIr-B/FOx; Anti-VEGF; Anti-EGFR;
Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis
Keywords: ضد VEGF; Laser therapy; Photocoagulation; Diabetes macular edema; Anti-VEGF; Subthreshold micropulse laser;
Tumor necrosis factor-α and diabetic retinopathy: Review and meta-analysis
Keywords: ضد VEGF; TNF-α; Tumor necrosis factor-α Interleukin-6; SMD; standard mean difference; CI; confidence interval; DR; diabetic retinopathy; NPDR; non-proliferative diabetic retinopathy; PDR; proliferative diabetic retinopathy; Anti-VEGF; anti-vascular endothelial g
Two year outcome in treatment-naive patients with neovascular age-related macular degeneration (nAMD) using an individualized regimen of Aflibercept
Keywords: ضد VEGF; Age-related macular degeneration; Anti-VEGF; Aflibercept; Individualized regimen; Dégénérescence maculaire liée à l'âge; Anti-VEGF; Aflibercept; Régime individualisé;
Serological inflammatory factors as biomarkers for anatomic response in diabetic macular edema treated with anti-VEGF
Keywords: ضد VEGF; Anti-VEGF; Bevacizumab; C-reactive protein; Diabetic macular edema; Inflammatory biomarkers;
Effects of bevacizumab, ranibizumab, and aflibercept on phagocytic properties in human RPE cybrids with AMD versus normal mitochondria
Keywords: ضد VEGF; Phagocytosis; Latex beads; Bevacizumab; Ranibizumab; Aflibercept; Anti-VEGF; Cybrids; Retinal pigment epithelium; Mitochondria; Age-related macular degeneration;
Prevention of corneal neovascularization by subconjunctival injection of avastin® loaded thermosensitive hydrogels in rabbit model
Keywords: ضد VEGF; Avastin®; Thermosensitive hydrogel; Anti-VEGF; Corneal neovascularization; Sustained release;
Bevacizumab with dose-dense paclitaxel/carboplatin as first-line chemotherapy for advanced ovarian cancer
Keywords: ضد VEGF; Ovarian cancer; Dose-dense chemotherapy; Bevacizumab; Anti-VEGF;
Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review
Keywords: ضد VEGF; cystoid macular edema; retinitis pigmentosa; treatment; systematic review; carbonic anhydrase inhibitor; anti-VEGF; laser;
Cas cliniqueMétastases choroïdiennes d'un adénocarcinome pulmonaire traité par injections intravitréennes d'anti-VEGF et irradiation externe : à propos d'un casChoroidal metastasis from a lung adenocarcinoma treated by intravitreal injection
Keywords: ضد VEGF; Métastases choroïdiennes; Radiothérapie; Anti-VEGF; Carcinome non à petites cellules pulmonaire; Choroidal metastasis; Radiotherapy; Anti-VEGF; Non-small cell lung cancer; NSCLC;
Inefficacité de l'aflibercept dans le traitement des télangiectasies maculaires idiopathiques de type 2Â sans néovascularisation
Keywords: ضد VEGF; Anti-VEGF; Télangiectasies maculaires idiopathiques; Aflibercept; MacTel; Anti-VEGF; Idiopathic macular telangiectasia; Aflibercept; MacTel; IMT2;
Résultats de la trabéculectomie associée aux anti-VGEF dans le traitement du glaucome néovasculaire compliquant les occlusions veineuses rétiniennes (à propos de 21 cas, suivis à la clinique ophtalmologique de Bukavu du 1er janvier au 31 décemb
Keywords: ضد VEGF; GNV; Anti-VEGF; Trabéculectomie; Pression intraoculaire; Résultats; Neovascular glaucoma; Trabeculectomy; Anti-VEGF; Intraocular pressure; Results;
Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
Keywords: ضد VEGF; Anti-VEGF; Bevacizumab; Ranibizumab; Aflibercept; Cornea;
Rétinopathie du prématuré
Keywords: ضد VEGF; Rétinopathie du prématuré; Dépistage; Angiogenèse; Stade seuil; Stade pré-seuil; Photocoagulation laser; Anti-VEGF; Retinopathy of prematurity; Screening; Angiogenesis; Threshold disease; Pre-threshold disease; Laser peripheral retinal ablation; VEG
Réponse visuelle et anatomique en condition de « vraie vie » du traitement par aflibercept chez les patients naïfs atteints de dégénérescence maculaire liée à l'âge exsudative
Keywords: ضد VEGF; Dégénérescence maculaire liée à l'âge exsudative; Patient naïf; Aflibercept; Ranibizumab; Anti-VEGF; Acuité visuelle; Ãpaisseur maculaire centrale; Exudative age-related macular degeneration; Treatment-naive patient; Aflibercept; Ranibizumab; A
Cellular stress response in human Müller cells (MIO-M1) after bevacizumab treatment
Keywords: ضد VEGF; Bevacizumab; Anti-VEGF; Müller cells; Retina; Caspase-3; Beclin-1; GFAP; Vimentin;
SCORE2 Report 2
Keywords: ضد VEGF; AMD; age-related macular degeneration; anti-VEGF; anti-vascular endothelial growth factor; BRVO; branch retinal vein occlusion; CRVO; central retinal vein occlusion; EDCCS; Eye Disease Case-Control Study; E-ETDRS; electronic Early Treatment Diabetic Ret
Electrospun formulations of bevacizumab for sustained release in the eye
Keywords: ضد VEGF; Coaxial electrospinning; Bevacizumab; Controlled release system; Core-shell fibers; Anti-VEGF; Poly-ε-caprolactone;
VasculopatÃa coroidea polipoidea bilateral, coexistiendo con degeneración macular asociada a la edad exudativa y atrófica
Keywords: ضد VEGF; Degeneración macular asociada a la edad; VasculopatÃa coroidea polipoidea; AngiografÃa con verde indocianina; Terapia fotodinámica; Anti-VEGF; Age-related macular degeneration; Polypoidal choroidal vasculopathy; Indocyanine angiography; Photodynamic t
Effets rénovasculaires des antiangiogéniques
Keywords: ضد VEGF; Anti-VEGF; Effets rénovasculaires; Protéinurie; Hypertension; Anti-VEGF; Renovascular effects; Proteinuria; Hypertension;
Étude des pratiques françaises dans la prise en charge de l’œdème maculaire diabétique
Keywords: ضد VEGF; Œdème maculaire diabétique; Anti-VEGF; Dexaméthasone; Fluocinolone; Évaluation des pratiquesDiabetic macular edema; Anti-VEGF; Dexamethasone; Fluocinolone; Practice patterns
Follow-up after surgery for hemorrhagic AMD
Keywords: ضد VEGF; Anti-VEGF; Follow-up; Intravitreal injection; Tissue plasminogen activator; Vitrectomy; Wet macular degeneration; Anti-VEGF; Suivi; Injection intravitréenne; Activateur tissulaire du plasminogène; Vitrectomie; DMLA exsudative;
Ranibizumab et dégénérescence maculaire liée à l'âge exsudative : analyse multicentrique à 5 ans des résultats fonctionnels et anatomiques en pratique clinique réelle
Keywords: ضد VEGF; Anti-VEGF; Dégénérescence maculaire liée à l'âge exsudative; Suivi à long terme; Régime PRN; Ranibizumab; Anti-vascular endothelial growth factor; Exudative age-related macular degeneration; Long-term follow-up; PRN regimen; Ranibizumab;
UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV
Keywords: ضد VEGF; AMD; age-related macular degeneration; ANCHOR; Anti-Vascular Endothelial Growth Factor Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration; anti-VEGF; inhibitor of vascular endothelial gro
Vue d'ensemble des pratiques médicales dans la DMLA exsudative en France
Keywords: ضد VEGF; DMLA exsudative; Pratiques des spécialistes de la rétine; Injections intravitréennes; Anti-VEGF; Parcours du patient; Wet AMD; Retinal specialist practices; Intravitreal injections; Anti-VEGF; Patient experience;
Aflibercept. Una aproximación a la farmacologÃa
Keywords: ضد VEGF; FarmacologÃa; Farmacocinética; Anti-VEGF; Aflibercept; Pharmacology; Pharmacokinetics; Anti-VEFG; Aflibercept;
Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity
Keywords: ضد VEGF; Bevacizumab; Retinopathy of prematurity; VEFG; Anti-VEGF; TreatmentLexemas; Bevacizumab; Retinopatía del prematuro; VEFG; Anti-VEGF; Tratamiento
Uso off-label de bevacizumab intravítreo en retinopatía del prematuro severa
Keywords: ضد VEGF; Lexemas; Bevacizumab; Retinopatía del prematuro; VEFG; Anti-VEGF; TratamientoBevacizumab; Retinopathy of prematurity; VEFG; Anti-VEGF; Treatment
Intérêt de la tomographie à cohérence optique réalisée immédiatement avant injection intra-vitréenne d'anti-VEGF sur récidive exsudative dans la DMLA
Keywords: ضد VEGF; Dégénérescence maculaire liée à l'âge; Anti-VEGF; Injection intra-vitréenne; Tomographie à cohérence optique; Bénéfice médico-économique; Age-related macular degeneration; Anti-VEGF; Intravitreal injection; Exudative recurrence management;
Combined hamartoma of the retina and retinal pigment epithelium. Anti-VEGF treatment of the associated choroidal neovascular membranes
Keywords: ضد VEGF; Hamartoma; Choroidal neovascularization; Membranes; Anti-VEGF; IatrogenicHamartoma; Neovascularización coroidea; Membranas; Anti-VEGF; Iatrogenia